Literature DB >> 1733629

HIV-induced deletion of antigen-specific T cell function is MHC restricted.

F Manca1, A Newell, M Valle, J Habeshaw, A G Dalgleish.   

Abstract

When antigen-specific T cells are pulsed by antigen-presenting cells (APC) in the presence of HIV they are functionally deleted following subsequent exposure to syngeneic APC in the absence of HIV. Recombinant soluble HIV envelope (gp120) is able to induce a similar effect which, unlike that induced by HIV, is reversible. Neither HIV nor gp120 affect the ability to respond to IL-2. Thus it is only antigen-specific responses involving the T cell receptor pathways and CD4/MHC class II interaction that appear to be inhibited by HIV-1 and gp120. Furthermore, the functional impairment caused by HIV-1 is specific to the T cells that respond to the antigen in co-culture with HIV, as there is no apparent effect on 'bystander'-activated T cells specific for another antigen. Antigen-specific T cell lines may be deleted by a signalling mechanism which involves molecules other than gp120/CD4 but still requires MHC class II restriction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733629      PMCID: PMC1554242          DOI: 10.1111/j.1365-2249.1992.tb06406.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  HIV envelope glycoprotein, antigen specific T-cell responses, and soluble CD4.

Authors:  F Manca; J A Habeshaw; A G Dalgleish
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321

Review 2.  T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex.

Authors:  R H Schwartz
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

3.  Impairment of in vitro immune responses occurs within 3 months after HIV-1 seroconversion.

Authors:  V J Teeuwsen; K H Siebelink; F de Wolf; J Goudsmit; F G UytdeHaag; A D Osterhaus
Journal:  AIDS       Date:  1990-01       Impact factor: 4.177

Review 4.  Macrophages and the human immunodeficiency virus.

Authors:  M S Meltzer; D R Skillman; D L Hoover; B D Hanson; J A Turpin; D C Kalter; H E Gendelman
Journal:  Immunol Today       Date:  1990-06

5.  Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition.

Authors:  H C Lane; J M Depper; W C Greene; G Whalen; T A Waldmann; A S Fauci
Journal:  N Engl J Med       Date:  1985-07-11       Impact factor: 91.245

Review 6.  Manipulation of T-cell responses with monoclonal antibodies.

Authors:  H Waldmann
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

7.  Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization.

Authors:  M E Harper; L M Marselle; R C Gallo; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

8.  HIV-1 transmission and function of virus-infected monocytes/macrophages.

Authors:  D L Mann; S Gartner; F Le Sane; H Buchow; M Popovic
Journal:  J Immunol       Date:  1990-03-15       Impact factor: 5.422

9.  Early lymphocyte transformation abnormalities in human immunodeficiency virus infection.

Authors:  D J Ridley; R W Houk; M J Reid; R N Boswell
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

10.  Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs.

Authors:  F Miedema; A J Petit; F G Terpstra; J K Schattenkerk; F de Wolf; B J Al; M Roos; J M Lange; S A Danner; J Goudsmit
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

View more
  2 in total

1.  Inhibitory activity of HIV envelope gp120 dominates over its antigenicity for human T cells.

Authors:  F Manca; L Walker; A Newell; F Celada; J A Habeshaw; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

2.  Association of T cell and macrophage dysfunction with surface gp 120-immunoglobulin-complement complexes in HIV-infected patients.

Authors:  V Daniel; C Süsal; R Weimer; R Zimmermann; A Huth-Kühne; G Opelz
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.